Molbox LLC

The International Partnership for Microbicides (IPM) is a global organization dedicated to expanding women's HIV prevention choices. For over 20 years, IPM has collaborated with partners across sectors and continents to develop innovative products, such as the monthly dapivirine ring, which has been approved in South Africa and recommended by the World Health Organization as a long-acting HIV prevention option. IPM's mission is to empower women by providing them with effective and accessible HIV prevention tools. Through their research, development, and advocacy efforts, IPM aims to create a healthier world where women have the power to protect themselves against HIV. Their commitment to woman-centered approaches and partnerships with organizations worldwide make them a leading force in the field of HIV prevention.Generated from the website

MedStar Research Institute is the research center of MedStar Health, a $2.7 billion nonprofit health care organization and a community-based network of seven hospitals and other health care services in the Baltimore-Washington region. The purpose of the institute is to conduct and support medical research that results in better treatments and prevention strategies for the major diseases affecting the communities it serves. The organization employs more than 23,000 staff members and 4,600 affiliated physicians. It serves more than 145,000 patients each day and more than 1 million patients each year. In 2005, MedStar Health co-sponsored the Bristol-Myers Squibb Tour of Hope fundraising bike ride. MedStar Research Institute is located in Hyattsville, Md.

Orgenesis Inc, based in Germantown, MD, is a pioneering company dedicated to unlocking the full potential of cell and gene therapies (CGTs) in an affordable and accessible format. Their innovative POCare Platform offers a pathway to lower costs and standardized CGTs, aiming to bring advanced therapies to patients globally. With a focus on personalized CGTs, Orgenesis is committed to addressing the world's most challenging diseases. Through collaborations with biotech industry leaders, research institutes, and hospitals, they are revolutionizing drug development and scale-up, making advanced therapies more accessible to those in need.Generated from the website